Oman Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Technology Reporter.

Press releases published on October 29, 2026

9 hours ago

Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

Indeterminate GlobeNewswire

9 hours ago

Aeluma to Announce First Quarter Fiscal Year 2027 Financial Results on November 12, 2026

Indeterminate GlobeNewswire

9 hours ago

Kobalt Labs Selected by Bangor Savings Bank to Streamline BaaS Risk and Compliance Management

Indeterminate GlobeNewswire

9 hours ago

C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders

Indeterminate GlobeNewswire

9 hours ago

BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Indeterminate GlobeNewswire

9 hours ago

Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals

Indeterminate GlobeNewswire

9 hours ago

Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth

Indeterminate GlobeNewswire

9 hours ago

Ligand Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)

Indeterminate GlobeNewswire

9 hours ago

Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

9 hours ago

Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations

Indeterminate GlobeNewswire

9 hours ago

Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences

Indeterminate GlobeNewswire

9 hours ago

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

Tilray Brands Announces Next Phase of Beverage Transformation

Indeterminate GlobeNewswire

9 hours ago

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026

Indeterminate GlobeNewswire

9 hours ago

Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting

Indeterminate GlobeNewswire

9 hours ago

Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026

Indeterminate GlobeNewswire

10 hours ago

SuccessKPI Positioned as Top 4 WEM Provider and Leader in the SPARK MatrixTM by Independent Analyst Firm QKS Group

Indeterminate GlobeNewswire

10 hours ago

Biosplice Executives to Appear on Health Uncensored with Dr. Drew on Sunday, November 1

Indeterminate GlobeNewswire

10 hours ago

Fortrea Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire